Why caregiver-reported symptoms matter early in rare pediatric neurodevelopmental disorders

In this webinar, discover how integrating caregiver-reported symptom data can provide actionable insights to address evidence gaps early in the development of therapies for rare pediatric neurodevelopmental disorders.

This webinar is designed to equip attendees with practical strategies for leveraging real-world patient and caregiver experiences to improve disease understanding, refine outcome measures, and generate patient-centered evidence that supports regulatory, HTA, and access discussions.

The non-profit organization Global Genes and admedicum™, tried to answer the key question: How can caregiver-reported symptom data help address evidence gaps in rare pediatric neurodevelopmental disorders?

You’ll see how RARE-X research-grade data, combined with human-led patient engagement, can support disease understanding, outcome-measure refinement, and patient-centered evidence generation.Using examples such as sleep-related symptoms, bulbar and communication challenges, and broader multi-system patterns, we will discuss how under-recognized burden can shape endpoint relevance, feasibility, and preparation for regulatory, HTA, and access discussions.

Designed for professionals in biopharma focused on early clinical development in rare diseases.

‍